Laboratorio Reig Jofre (XMAD:RJF) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:RJF Laboratorio Reig Jofre SA XMAD:RJF
80 GF Score
Price €2.62
GF Value €2.72
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Laboratorio Reig Jofre Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

XMAD:RJF
80GF Score
Laboratorio Reig Jofre SA XMAD:RJF
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Laboratorio Reig Jofre (XMAD:RJF) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Reig Jofre stock appears to be undervalued. The current stock price of €2.62 is trading 3.7% below its estimated GF Value™ of €2.72. GuruFocus considers Laboratorio Reig Jofre to be Fairly Valued.

Key valuation signals for XMAD:RJF:

  • Dividends Received:
  • GF Value™: €2.72 vs. price of €2.62 (3.7% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the XMAD:RJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Reig Jofre Business Description

Other Exchanges 0RB1:UKFEQ1:Germany
Address Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
80GF Score

Get the complete analysis for XMAD:RJF

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.62
Price
€2.72
GF Value